MedPath

Effect of nalbuphine versus fentanyl as an adjuvant in epidural anesthesia

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/09/036643
Lead Sponsor
SMS medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Consent for participation in study

2. Patients posted for urological surgeries belonging to ASA grade 1 and 2

3. Weigh 45 to 70 kg

Exclusion Criteria

1.Obese patients , uncontrollable hypertension, uncontrollable diabetes mellitus ,severe CVS malformation,renal or hepatic failure , with the history of neurological surgeries

2 . H/o spinal surgery , spinal deformity or infection at local site

3 . Coagulation defects those on anticoagulants

4 . Allergic to any of concerned drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
time duration after which first rescue analgesia requiredTimepoint: After surgery when VAS score is 4 or more
Secondary Outcome Measures
NameTimeMethod
To determine the mean VAS score for first 6 hour , 6 to 12 and 12 to 24 hours. <br/ ><br>2.To determine the percentage of cases who develop side effect( if any ) in both the groups.Timepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath